Kentucky, Alaska and Alabama are the three states where weight loss drugs ... U.S. Food and Drug Administration (FDA) approved the semaglutide-based drug Wegovy for obesity. Before Wegovy, 190,000 ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.O ...

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss). Following ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

“There are no guarantees to avoid sickness as winter is open season for cold and flu viruses, but some basics include good ...

Pfizer earnings and revenue comfortably beat Q3 estimates, with the pharma giant raising full-year guidance. Shares rose Tuesday.

Alzheimer's disease (AD) is a progressive brain disorder that gradually destroys memory and cognitive abilities, affecting ...

US authorities targeted fake online pharmacies selling counterfeit prescription pills laced with fentanyl and methamphetamine.